Predicting AIDS onset for individual patients.
暂无分享,去创建一个
[1] G Reibnegger,et al. Individual probability for onset of full-blown disease in patients infected with human immunodeficiency virus type 1. , 1991, Clinical chemistry.
[2] W. Guerra. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter , 1991 .
[3] M. Desco,et al. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV‐infected drug users , 1990, AIDS.
[4] P. Volberding,et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. , 1990, The New England journal of medicine.
[5] J. Goedert,et al. Markers of risk in HIV-1. , 1990, The New England journal of medicine.
[6] J. Montaner,et al. Susceptibility to AIDS progression appears early in HIV infection , 1990, AIDS.
[7] J M Taylor,et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.
[8] J. Goedert,et al. Levels of CD4+ lymphocytes, neopterin and ß2-microglobulin are early predictors of AIDS , 1990 .
[9] J. Goedert,et al. Therapy may explain recent deficits in AIDS incidence. , 1990, Journal of acquired immune deficiency syndromes.
[10] Recommendations for zidovudine: early infection. , 1990, JAMA.
[11] G. Rutherford,et al. Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. , 1989, American journal of epidemiology.
[12] J. Goedert,et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. , 1989, The New England journal of medicine.
[13] J. Goedert,et al. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count. , 1989, Annals of internal medicine.
[14] Peter Bacchetti,et al. Incubation period of AIDS in San Francisco , 1989, Nature.
[15] J J Goedert,et al. Censoring in an epidemic with an application to hemophilia-associated AIDS. , 1989, Biometrics.
[16] W. Blattner,et al. Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. , 1989, Journal of acquired immune deficiency syndromes.
[17] A. McBryde. Acquired immunodeficiency syndrome (AIDS) , 2019, North Carolina medical journal.
[18] R. Chaisson,et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort , 1988, British medical journal.
[19] E. Werner,et al. Neopterin as a marker in HIV infection. , 1988, Clinical chemistry.
[20] M A Fischl,et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.
[21] J. Goedert,et al. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. , 1987, Annals of internal medicine.
[22] J. Goedert,et al. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. , 1987, JAMA.
[23] S. Zolla-Pazner,et al. Quantitation of β2-Microglobulin and Other Immune Characteristics in a Prospective Study of Men at Risk for Acquired Immune Deficiency Syndrome , 1984 .
[24] J. Goedert,et al. Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. , 1983, The New England journal of medicine.
[25] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .